Tranont announced Dr. Erin Glynn has been named to its Scientific Advisory Board. Dr. Glynn is an expert in metabolic health, nutrition and product development and brings more than two decades of experience in both academia and the dietary supplement industry.

In this new role, Dr. Glynn will oversee scientific product development, guide the company’s leadership team through product innovation and provide educational support to Tranont associates.

“Dr. Glynn’s expertise in metabolic and gut health will be instrumental in driving future product innovations, particularly in underserved areas like women’s health,” said Russell Losee, Tranont Co-Founder and COO. “Her holistic approach aligns perfectly with Tranont’s commitment to developing life-changing health products and providing associates with the resources they need to succeed.”

Tranont described Dr. Glynn’s new appointment as highlighting its “focus on women’s health” and said Dr. Glynn will play a prominent role in shaping and communicating the brand’s mission to “simplify women’s health with effective, science-backed products that integrate seamlessly into daily life.”